NCT05294510

Brief Summary

This is a stepped wedge, cluster randomized study of a clinical algorithm that includes point-of-care C-reactive protein testing to inform antibiotic treatment decisions by village health workers for children presenting with acute respiratory illness in the Bugoye sub-county of the Kasese District in southwestern Uganda. The purpose of this study is to assess the impact of the algorithm on antibiotic use.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,280

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 2, 2021

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

March 15, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 24, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2022

Completed
Last Updated

August 4, 2022

Status Verified

August 1, 2022

Enrollment Period

7 months

First QC Date

March 15, 2022

Last Update Submit

August 3, 2022

Conditions

Keywords

Community health workersC-reactive protein

Outcome Measures

Primary Outcomes (1)

  • Antibiotic prescriptions at baseline visit

    Proportion of children prescribed antibiotics by the village health worker at the baseline visit in the control as compared to the intervention condition.

    Baseline visit

Secondary Outcomes (8)

  • Clinical Failure (Composite Outcome)

    Between baseline visit and Day 7 follow-up assessment

  • Unexpected visits

    Between baseline visit and Day 7 follow-up assessment

  • Perceived improvement per caregiver

    Day 7

  • Persistent fever

    Day 7

  • Development of danger signs

    Between Day 1 and Day 7

  • +3 more secondary outcomes

Study Arms (2)

Control

NO INTERVENTION

Children who present to a village health worker during a control period are evaluated and managed using the current standard of care per Uganda National Guidelines for Integrated Community Case Management (ICCM). Each village will experience both Control and Intervention conditions as the study employs a stepped wedge design.

Intervention

EXPERIMENTAL

Children who present to a village health worker during an intervention period are evaluated and managed using a modified ICCM algorithm that includes point-of-care C-reactive protein testing. Each village will experience both Control and Intervention conditions as the study employs a stepped wedge design.

Other: STAR Sick Child Job Aid

Interventions

The STAR Sick Child Job Aid is a modified ICCM protocol that includes the addition of a point-of-care C-reactive protein (CRP) test to inform antibiotic treatment decisions for children presenting with febrile acute respiratory illness who do not have any danger signs. If CRP ≥ 40 mg/L, the village health worker (VHW) will dispense amoxicillin per local guidelines. If CRP \< 40 mg/L, the VHW will advise symptomatic care alone including acetaminophen for fever and additional fluids to maintain hydration.

Intervention

Eligibility Criteria

Age2 Months - 5 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age 2 months-5 years
  • Evaluated by a study VHW in one of the participating villages in Bugoye sub-county for acute respiratory illness defined as the following: fever (documented (temperature \> 38°C) or subjective fever in the last seven days) AND fast breathing (respiratory rate \> 30) OR cough

You may not qualify if:

  • Age \> 5 years or \< 2 months at time of presentation
  • Guardian not present to provide consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bugoye Health Center III

Bugoye, Kasese District, Uganda

Location

Related Publications (1)

  • Ciccone EJ, Hu D, Preisser JS, Cassidy CA, Kabugho L, Emmanuel B, Kibaba G, Mwebembezi F, Juliano JJ, Mulogo EM, Boyce RM. Point-of-care C-reactive protein measurement by community health workers safely reduces antimicrobial use among children with respiratory illness in rural Uganda: A stepped wedge cluster randomized trial. PLoS Med. 2024 Aug 19;21(8):e1004416. doi: 10.1371/journal.pmed.1004416. eCollection 2024 Aug.

Study Officials

  • Emily J Ciccone, MD, MHS

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Model Details: Stepped wedge, cluster randomized trial with 5 clusters or treatment sequences of 3 villages each. Villages are first stratified by altitude, proximity to the local health center, and size (based on approximate number of children seen by the village health workers per year) into one of three strata: (1) low altitude, proximal, large, (2) low altitude, mid-distance, medium, (3) high altitude, distal, small. One village is then randomly selected from each strata for each of the 5 clusters. All clusters start in the control condition and one cluster crosses over from control to intervention each month.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 15, 2022

First Posted

March 24, 2022

Study Start

November 2, 2021

Primary Completion

May 30, 2022

Study Completion

May 30, 2022

Last Updated

August 4, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will share

Deidentified individual data that underlie the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.

Shared Documents
STUDY PROTOCOL, ICF, CSR, ANALYTIC CODE
Time Frame
9 months to 36 months after publication
Access Criteria
The investigator who proposes to use the data has approval from an IRB, IEC, or REB, as applicable, and an executed data use/sharing agreement with UNC

Locations